REMCX
Price
$14.55
Change
+$0.10 (+0.69%)
Updated
Jan 17 closing price
Net Assets
725.04M
VEMRX
Price
$92.22
Change
+$0.58 (+0.63%)
Updated
Jan 17 closing price
Net Assets
108.96B
Ad is loading...

REMCX vs VEMRX

Header iconREMCX vs VEMRX Comparison
Open Charts REMCX vs VEMRXBanner chart's image
Russell Inv Emerging Markets C
Price$14.55
Change+$0.10 (+0.69%)
VolumeN/A
Net Assets725.04M
Vanguard Emerging Mkts Stock Idx InsPlus
Price$92.22
Change+$0.58 (+0.63%)
VolumeN/A
Net Assets108.96B
REMCX vs VEMRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
REMCX vs. VEMRX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REMCX is a Hold and VEMRX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEMRX has more cash in the bank: 109B vs. REMCX (725M). VEMRX pays higher dividends than REMCX: VEMRX (3.48) vs REMCX (1.54). REMCX was incepted earlier than VEMRX: REMCX (26 years) vs VEMRX (14 years). REMCX is a more actively managed with annual turnover of: 95.00 vs. VEMRX (5.00). REMCX has a lower initial minimum investment than VEMRX: REMCX (0) vs VEMRX (100000000). VEMRX (13.91) and REMCX (13.56) have marching annual gain over last year. VEMRX return over 5 years is better than : 6.00 vs. REMCX (-17.79).
REMCXVEMRXREMCX / VEMRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence26 years14 years-
Gain YTD0.622-0.839-74%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets725M109B1%
Annual Yield % from dividends1.543.4844%
Returns for 1 year13.5613.9197%
Returns for 3 years-12.76-5.19246%
Returns for 5 years-17.796.00-297%
Returns for 10 years-3.5629.74-12%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMS3.220.12
+3.87%
American Shared Hospital Services
RGCO20.860.57
+2.80%
RGC Resources
RNA28.920.63
+2.23%
Avidity Biosciences
TCPC8.950.09
+1.02%
BlackRock TCP Capital Corp
CELH27.23-0.36
-1.30%
Celsius Holdings